Answers are grounded in this paper and cite their sources.
Cancer remains one of the most critical global health challenges, characterized by its complex molecular mechanisms. Among the myriad of molecular players implicated in cancer progression, Rab-like protein 1A (RBEL1A), a member of the Ras superfamily of small GTPases, has emerged as a promising candidate for further investigation due to its oncogenic characteristics. Despite tremendous efforts in investigating the functional properties of this protein in the past, its interacting partners and regulatory networks remain poorly understood, necessitating a comprehensive investigation. Our study employed a multiomics strategy combining transcriptomics, proteomics, and affinity-based proteomics. This encompasses immunoprecipitation coupled with liquid chromatography-mass spectrometry to characterize the RBEL1A interactome, along with global proteomic profiling of cells with RBEL1A knockout or overexpression. Given the central role of protein–protein interactions in regulating biological processes, our proteomic interactome analysis demonstrates for the first time distinct clusters of RBEL1A-interacting proteins, participating in four key cellular functions: cytoskeletal organization and cell migration, vesicular trafficking, DNA damage repair, and RNA splicing regulation. This study also represents the first comprehensive and systematic analysis of RBEL1A global proteomic data showing differentially expressed proteins in RBEL1A knockout and overexpressing cells, which provides novel insights into its complex functional networks.
No takes yet. Share an insight, caveat, or question.
Lui et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: